149 related articles for article (PubMed ID: 26402728)
1. Synthesis and antibacterial activity of 4″-O-(trans-β-arylacrylamido)carbamoyl azithromycin analogs.
Yan M; Ma X; Dong R; Li X; Zhao C; Guo Z; Shen Y; Liu F; Ma R; Ma S
Eur J Med Chem; 2015 Oct; 103():506-15. PubMed ID: 26402728
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Antibacterial Evaluation of a Series of 11,12-Cyclic Carbonate Azithromycin-3-O-descladinosyl-3-O-carbamoyl Glycosyl Derivatives.
Wang CM; Zhao FL; Zhang L; Chai XY; Meng QG
Molecules; 2017 Dec; 22(12):. PubMed ID: 29207567
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of novel 3-O-descladinosylazithromycin derivatives.
Yan M; Ma R; Jia L; Venter H; Ma S
Eur J Med Chem; 2017 Feb; 127():874-884. PubMed ID: 27836198
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.
Ma S; Ma R; Liu Z; Ma C; Shen X
Eur J Med Chem; 2009 Oct; 44(10):4010-20. PubMed ID: 19464769
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial evaluation of novel 11,4″-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria.
Li X; Ma S; Yan M; Wang Y; Ma S
Eur J Med Chem; 2013 Jan; 59():209-17. PubMed ID: 23229056
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of novel 3-O-carbamoyl derivatives of clarithromycin and 11,12-cyclic carbonate azithromycin.
Zhang L; Song L; Liu Z; Li H; Lu Y; Li Z; Ma S
Eur J Med Chem; 2010 Mar; 45(3):915-22. PubMed ID: 19945195
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Ma C; Liu Z; Song H; Jiang R; He F; Ma S
J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of 11,12-cyclic carbonate 4″-O-aralkylacetylhydrazineacyl azithromycin derivatives.
Yan M; Xu L; Wang Y; Wan J; Chenchen ; Li Q; Wang R
Bioorg Chem; 2020 Jan; 94():103475. PubMed ID: 31791683
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.
Zheng Z; Du D; Cao L; Liu J; Chen X
J Antibiot (Tokyo); 2016 Nov; 69(11):811-817. PubMed ID: 27118243
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents.
Zhang L; Chai X; Wang B; Yu S; Hu H; Zou Y; Zhao Q; Meng Q; Wu Q
Bioorg Med Chem Lett; 2013 Sep; 23(18):5057-60. PubMed ID: 23937982
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
Pavlović D; Mutak S
Bioorg Med Chem; 2016 Mar; 24(6):1255-67. PubMed ID: 26860929
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
Qi Y; Jiao B; Ma X; Cui W; Ma S
Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether.
Zhang L; Jiao B; Yang X; Liu L; Ma S
J Antibiot (Tokyo); 2011 Mar; 64(3):243-7. PubMed ID: 21245870
[TBL] [Abstract][Full Text] [Related]
15. Novel C-4'' modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: the synthesis and antimicrobial evaluation.
Ma X; Zhang L; Wang R; Cao J; Liu C; Fang Y; Wang J; Ma S
Eur J Med Chem; 2011 Oct; 46(10):5196-205. PubMed ID: 21855183
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of 4'',11-di-O-arylalkylcarbamoyl azithromycin derivatives.
Ma S; Jiao B; Liu Z; Wang H; Xian R; Zheng M; Lou H
Bioorg Med Chem Lett; 2009 Mar; 19(6):1698-701. PubMed ID: 19232491
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives.
Jia L; Wang Y; Wang Y; Qin Y; Hu C; Sheng J; Ma S
Bioorg Med Chem Lett; 2018 Aug; 28(14):2471-2476. PubMed ID: 29880401
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and structure-activity relationship studies of conformationally restricted mutilin 14-carbamates.
Fu L; Liu X; Ling C; Cheng J; Guo X; He H; Ding S; Yang Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):814-9. PubMed ID: 22209487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
